Molecular allergology allows your laboratory to measure sensitization to specific allergen components, which helps to identify, on a molecular level, which component proteins your clinician’s patients are sensitized to.
1. Assess the Clinical Risk for Reaction
Sensitization to allergen components that are stable may elicit both systemic and local reactions, while sensitization to labile components is mainly associated with local reactions.3-8 This information can help a clinician narrow the patient’s diagnosis.
2. Explain Symptoms Due to Cross-Reactivity
Symptoms elicited by cross-reacting antibodies can be distinguished from those caused by genuine sensitization, which can help a clinician refine the patient’s treatment plan. In addition, in cases where only cross-reactive sensitization is identified, your laboratory may be able to assist with further testing to find the primary sensitizer.
3. Identify Appropriate Allergens for Improved Allergy Immunotherapy Outcomes
By helping clinicians match patients who have a genuine sensitization with an extract from the relevant source, your laboratory can play a role in improving patients’ treatment outcomes.
4. Can Help You Decrease the Need for Provocation Testing and Improve Recommendations for Allergen Avoidance
Detecting “low-risk” versus “high-risk” molecules could reduce the use of potentially harmful diagnostic procedures such as challenge tests.